Friso G J Calkoen

16PUBLICATIONS
122CO-AUTHORS
Molecular targetsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Adolescent healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 07, 2026
TAMing the tumor: targeting immune inhibitory receptors on tumor-associated macrophages in pediatric brain tumors - an emerging immunotherapy strategy.

|Aug 31, 2026
Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome.

|May 21, 2026
Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort.

|Nov 19, 2025
Outcomes of BCP-ALL with hypodiploidy or BCR::ABL1 fusion in children undergoing allogeneic HSCT: results from the FORUM study.

Jochen Buechner, Ulrike Poetschger, Peter Bader

|May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies.

Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude

|Mar 13, 2025
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.

Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts-Riemens

Pageof 3

Frequent Collaborators

4 joint publications

Peter Bader

3 joint publications

Franco Locatelli

2 joint publications

Rafael de La Camara

2 joint publications

Pere Barba